Thousands of Sask. patients could benefit from new technology replacing colonoscopies
medscape.com
FDA Panel Votes to Favor High Dose Xeljanz in Ulcerative Colitis
Yesterday a FDA advisory panel voted 15-0 in favor of approving Xeljanz (tofacitinib) 10 mg bid for patients with moderate to severe ulcerative…
rheumnow.com
businesswire.com
FDA Grants Orphan Drug Designation to Potential Pediatric Ulcerative Colitis Treatment
This morning, Seres Therapeutics announced that the FDA has granted Orphan Drug Designation to SER-287 for the treatment of Ulcerative Colitis in…
raredr.com
